Transform CV Risk in Diabetes
Status unconfirmed · Not applicable
Conditions studied: Type 2 Diabetes
In brief
This initiative supports a real-world study of practice and physician prescribing patterns and a quality improvement initiative evaluating best practices (including clinical decision support, facilitated referral to cardiometabolic team-based care model, and general educational tools/resources) to im-prove use of guideline-directed therapeutics known to lower cardiovascular risk (CV) in patients with type 2 diabetes (T2D).
Key facts
- Study ID
- NCT05948969
- Run by
- American College of Cardiology
- People needed
- 750
- Starts
- 2023-09-01
- Expected to finish
- 2024-12-31
- Last updated by the study team
- 2023-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- T2D diagnosis in the medical record
- ASCVD, defined as follows:
- Known Coronary artery disease (CAD), prior Acute coronary syndrome (ACS), or coronary artery revascularization
- Prior TIA/ischemic stroke or known carotid or intracerebral atherosclerosis, or prior carotid revascularization
- Prior Peripheral artery disease (PAD) including symptomatic claudication or pe-ripheral revascularization
You may not qualify if…
- Current participation in an interventional clinical assessment of an investigational drug/device (excluding assessments related to COVID-19)
- Currently receiving any SGLT2i or GLP-1RA
- Known allergy/hypersensitivity/intolerance/contraindication to SGLT2i or GLP-1RA
- Currently receiving comfort care or enrolled in hospice
- Life expectancy <1 year
- History of or plan for heart transplantation or ventricular assist device
- Current or planned hemodialysis
- Decompensated end stage liver disease
- History of Fournier's Gangrene
- Type 1 diabetes
- Prior history of diabetic ketoacidosis
- Pregnancy or active breastfeeding
- History of Pancreatitis or pancreatic cancer
- History of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN-2)
Where it is running
- Multiple sites nationwide — Washington D.C., District of Columbia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.